FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090553069> ?p ?o ?g. }

• W2090553069 endingPage "132" @default.
• W2090553069 startingPage "124" @default.
• W2090553069 abstract "Atherosclerosis is the principal cause of mortality in industrialized countries. Its development is influenced by several mediators of which thromboxane A(2) (TXA(2)) and 8-iso-PGF(2α) have recently received a lot of attention. This study aimed to investigate the effect of a dual thromboxane synthase inhibitor and thromboxane receptor antagonist (BM-573) and ASA on lesion formation in apolipoprotein E-deficient mice. The combination of ASA and BM-573 was also studied. Plasma measurements demonstrated that the treatments did not affect body weight or plasma cholesterol levels. BM-573, but not ASA, significantly decreased atherogenic lesions as demonstrated by macroscopic analysis. Both treatments alone inhibited TXB(2) synthesis but only BM-573 and the combination therapy were able to decrease firstly, plasma levels of soluble intracellular adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) and secondly, the expression of these proteins in the aortic root of Apo E. These results were confirmed in endothelial cell cultures derived from human saphenous vein endothelial cells (HSVECs). In these cells, BM-573 also prevented the increased mRNA expression of ICAM-1 and VCAM-1 induced by U-46619 and 8-iso-PGF(2α). Our results show that a molecule combining receptor antagonism and thromboxane synthase inhibition is more efficient in delaying atherosclerosis in Apo E(-/-) mice than sole inhibition of TXA(2) formation." @default.
• W2090553069 created "2016-06-24" @default.
• W2090553069 creator A5017813188 @default.
• W2090553069 creator A5020553356 @default.
• W2090553069 creator A5020685154 @default.
• W2090553069 creator A5024962592 @default.
• W2090553069 creator A5025895018 @default.
• W2090553069 creator A5029672591 @default.
• W2090553069 creator A5041424887 @default.
• W2090553069 creator A5047554635 @default.
• W2090553069 creator A5057995841 @default.
• W2090553069 creator A5081430054 @default.
• W2090553069 creator A5082090154 @default.
• W2090553069 creator A5087763748 @default.
• W2090553069 date "2011-04-01" @default.
• W2090553069 modified "2023-09-30" @default.
• W2090553069 title "BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthase" @default.
• W2090553069 cites W1492270522 @default.
• W2090553069 cites W1859624620 @default.
• W2090553069 cites W1967492851 @default.
• W2090553069 cites W1970981593 @default.
• W2090553069 cites W1972153352 @default.
• W2090553069 cites W1982789996 @default.
• W2090553069 cites W2012690683 @default.
• W2090553069 cites W2018716226 @default.
• W2090553069 cites W2026652904 @default.
• W2090553069 cites W2034726329 @default.
• W2090553069 cites W2048009051 @default.
• W2090553069 cites W2053230224 @default.
• W2090553069 cites W2054499451 @default.
• W2090553069 cites W2060453286 @default.
• W2090553069 cites W2063052712 @default.
• W2090553069 cites W2066044812 @default.
• W2090553069 cites W2074337679 @default.
• W2090553069 cites W2079115802 @default.
• W2090553069 cites W2081332101 @default.
• W2090553069 cites W2083403064 @default.
• W2090553069 cites W2106033501 @default.
• W2090553069 cites W2109212247 @default.
• W2090553069 cites W2123103466 @default.
• W2090553069 cites W2124939010 @default.
• W2090553069 cites W2143648826 @default.
• W2090553069 cites W2146972322 @default.
• W2090553069 cites W2147204790 @default.
• W2090553069 cites W2152021373 @default.
• W2090553069 cites W2152396641 @default.
• W2090553069 cites W2157603347 @default.
• W2090553069 cites W2157623431 @default.
• W2090553069 cites W2167740507 @default.
• W2090553069 cites W2316102942 @default.
• W2090553069 doi "https://doi.org/10.1016/j.prostaglandins.2011.03.001" @default.
• W2090553069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21397034" @default.
• W2090553069 hasPublicationYear "2011" @default.
• W2090553069 type Work @default.
• W2090553069 sameAs 2090553069 @default.
• W2090553069 citedByCount "16" @default.
• W2090553069 countsByYear W20905530692012 @default.
• W2090553069 countsByYear W20905530692013 @default.
• W2090553069 countsByYear W20905530692014 @default.
• W2090553069 countsByYear W20905530692015 @default.
• W2090553069 countsByYear W20905530692016 @default.
• W2090553069 countsByYear W20905530692017 @default.
• W2090553069 countsByYear W20905530692018 @default.
• W2090553069 countsByYear W20905530692020 @default.
• W2090553069 countsByYear W20905530692021 @default.
• W2090553069 countsByYear W20905530692022 @default.
• W2090553069 crossrefType "journal-article" @default.
• W2090553069 hasAuthorship W2090553069A5017813188 @default.
• W2090553069 hasAuthorship W2090553069A5020553356 @default.
• W2090553069 hasAuthorship W2090553069A5020685154 @default.
• W2090553069 hasAuthorship W2090553069A5024962592 @default.
• W2090553069 hasAuthorship W2090553069A5025895018 @default.
• W2090553069 hasAuthorship W2090553069A5029672591 @default.
• W2090553069 hasAuthorship W2090553069A5041424887 @default.
• W2090553069 hasAuthorship W2090553069A5047554635 @default.
• W2090553069 hasAuthorship W2090553069A5057995841 @default.
• W2090553069 hasAuthorship W2090553069A5081430054 @default.
• W2090553069 hasAuthorship W2090553069A5082090154 @default.
• W2090553069 hasAuthorship W2090553069A5087763748 @default.
• W2090553069 hasConcept C126322002 @default.
• W2090553069 hasConcept C134018914 @default.
• W2090553069 hasConcept C16224149 @default.
• W2090553069 hasConcept C170493617 @default.
• W2090553069 hasConcept C173202427 @default.
• W2090553069 hasConcept C185592680 @default.
• W2090553069 hasConcept C203014093 @default.
• W2090553069 hasConcept C2776785769 @default.
• W2090553069 hasConcept C2776885963 @default.
• W2090553069 hasConcept C2778122271 @default.
• W2090553069 hasConcept C2778163477 @default.
• W2090553069 hasConcept C2780072125 @default.
• W2090553069 hasConcept C2781024287 @default.
• W2090553069 hasConcept C43554185 @default.
• W2090553069 hasConcept C51603380 @default.
• W2090553069 hasConcept C55493867 @default.
• W2090553069 hasConcept C62746215 @default.
• W2090553069 hasConcept C71924100 @default.
• W2090553069 hasConcept C89560881 @default.

• next